CircHIPK3 promotes the progression of B-cell acute lymphoblastic leukemia in children by binding to STAT3
The findings characterize circHIPK3 as a potent oncogenic driver in B-ALL that functions by stabilizing STAT3 via the ubiquitin-proteasome pathway.